Clinical Trial Update: Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions

View source ↗

Summary

The trial evaluated the diagnostic precision of the Dermalyzer AI tool for identifying malignant melanoma in primary care patients with melanoma-suspected lesio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Snippet

Sponsor: Linkoeping University | Conditions: Malignant Melanoma | Status: COMPLETED | Results posted: 2025-02-05